GIM
GILD icon

Goelzer Investment Management’s Gilead Sciences GILD Stock Holding History

Goelzer Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,077
Closed -$237K – 251
2020
Q2 		$237K Buy
3,077
+182
+6% +$13.9K 0.02% 225
2020
Q1 		$216K Buy
+2,895
New +$200K 0.02% 227
2019
Q4 		– Sell
-3,239
Closed -$205K – 249
2019
Q3 		$205K Buy
3,239
+135
+4% +$8.82K 0.02% 245
2019
Q2 		$210K Sell
3,104
-50
-2% -$3.29K 0.02% 252
2019
Q1 		$205K Buy
+3,154
New +$210K 0.02% 264
2018
Q4 		– Sell
-64,836
Closed -$5.01M – 199
2018
Q3 		$5.01M Sell
64,836
-526
-0.8% -$39.7K 0.56% 76
2018
Q2 		$4.63M Sell
65,362
-895
-1% -$63.2K 0.54% 78
2018
Q1 		$5M Sell
66,257
-1,703
-3% -$135K 0.6% 68
2017
Q4 		$4.87M Sell
67,960
-2,537
-4% -$193K 0.55% 79
2017
Q3 		$5.71M Sell
70,497
-1,512
-2% -$116K 0.67% 49
2017
Q2 		$5.1M Sell
72,009
-15,031
-17% -$1M 0.62% 58
2017
Q1 		$5.91M Buy
87,040
+12,976
+18% +$912K 0.74% 43
2016
Q4 		$5.3M Buy
74,064
+278
+0.4% +$20.7K 0.69% 48
2016
Q3 		$5.84M Buy
73,786
+10,189
+16% +$828K 0.79% 34
2016
Q2 		$5.3M Sell
63,597
-2,371
-4% -$210K 0.73% 42
2016
Q1 		$6.06M Sell
65,968
-27,231
-29% -$2.46M 0.87% 28
2015
Q4 		$9.43M Buy
93,199
+77
+0.1% +$8.01K 1.38% 7
2015
Q3 		$9.14M Buy
93,122
+218
+0.2% +$24.2K 1.45% 6
2015
Q2 		$10.9M Buy
92,904
+11,185
+14% +$1.22M 1.64% 3
2015
Q1 		$8.02M Buy
81,719
+8,985
+12% +$912K 1.21% 11
2014
Q4 		$6.86M Sell
72,734
-535
-0.7% -$55.3K 1.04% 21
2014
Q3 		$7.8M Sell
73,269
-1,657
-2% -$162K 1.3% 9
2014
Q2 		$6.21M Buy
74,926
+1,131
+2% +$88K 1.03% 27
2014
Q1 		$5.23M Buy
73,795
+1,042
+1% +$81.7K 0.93% 34
2013
Q4 		$5.46M Sell
72,753
-31,472
-30% -$2.19M 0.99% 28
2013
Q3 		$6.55M Sell
104,225
-108,625
-51% -$6.49M 1.34% 6
2013
Q2 		$10.9M Buy
+212,850
New +$11.1M 1.16% 17

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Goelzer Investment Management's GILD Position: Q3 2020 in Review

Goelzer Investment Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,077 shares — an estimated $237K sold.

Goelzer Investment Management first reported a position in GILD in Q2 2013 and held it in 27 quarters. The position peaked at $10.9M in Q2 2013. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Goelzer Investment Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Goelzer Investment Management sold 3,077 Gilead Sciences shares in Q3 2020, an estimated $237K.
  • Goelzer Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 27 quarters.
  • Goelzer Investment Management's Gilead Sciences position peaked at $10.9M in Q2 2013.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Goelzer Investment Management's 13F filing for Q3 2020, filed 27 Oct 2020.